<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04329247</url>
  </required_header>
  <id_info>
    <org_study_id>CE0072015-02-04</org_study_id>
    <nct_id>NCT04329247</nct_id>
  </id_info>
  <brief_title>Physical Therapy in the Treatment of Carpal Tunnel Syndrome</brief_title>
  <official_title>Physical Therapy Versus Control in the Treatment of Carpal Tunnel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Europea de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Europea de Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present investigation the pain reduction effects of a physical therapy technique will
      be compared to those produced by the absence of treatment, in subjects who suffer the signs
      and symptoms of carpal tunnel syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present randomized clinical trial will perform a comparison of the pain reduction effect
      produced by the application of the median nerve neural mobilization technique (a non
      pharmaceutical physical therapy treatment), to the pain reduction effect produced by the
      total absence of treatment in subjects who suffer carpal tunnel syndrome. Functionality of
      the affected upper limb will be evaluated and compared. Subjects will be invited to
      participate and randomly allocated to 2 different groups.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distal upper limb pain</measure>
    <time_frame>: Changes from baseline (measured immediately before the application of each treatment) at 40 minutes after the application of treatment. Measures at baseline and after treatment will be performed 1 day a week during 4 weeks.</time_frame>
    <description>Assessed through the visual analog scale (VAS). The VAS is a psychometric response scale. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured.The VAS is the most frequently used method to assess pain intensity. The scale will be displayed as a horizontal 100-mm line labelled at each end by descriptors such as 'no pain' (the minimum and best outcome possible) and 'worse pain ever' (maximum and worst outcome possible). The participant will mark the line to indicate pain severity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Upper limb function</measure>
    <time_frame>Changes from baseline (measured immediately before the application of the first treatment), and at 40 minutes after the application of the last treatment.</time_frame>
    <description>Assessed through the quick Quick Disabilities of the Arm, Shoulder and Hand questionary (QuickDASH), which is a shortened version of the 30-item Disabilities of the Arm, Shoulder and Hand (DASH) instrument.The instrument administered to the participants will be a self-report questionnaire, that will rate the difficulty and interference of daily life on a 5 point Likert scale. At least 10 of the 11 items must be completed for a score to be calculated and the scores range from 0 (no disability) to 100 (most severe disability).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>Median nerve neural mobilization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non pharmaceutical, non invasive, physiotherapy technique; which consists of a passive and repetitive upper limb movement that seeks to induced median nerve gliding and incursions against surrounding connective tissue. Subjects will be treated 5 days per week during a total time lapse of 6 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Waiting list control group. Participants that belong to the no intervention arm will be assigned to a waiting list to receive treatment. The participants will not receive treatment for carpal tunnel syndrome during a time lapse of 6 weeks. After this period of time, participants will begin the best treatment available.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Median nerve neural mobilization</intervention_name>
    <description>Manual therapy maneuver performed in the upper limb.</description>
    <arm_group_label>Median nerve neural mobilization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with
             confirmative electrodiagnostic findings).

               -  Full understanding of written and spoken Spanish (language).

               -  Participants must freely consent to participate.

               -  The presence of positive Phalen an Tinel sings.

               -  The presence of carpal tunnel syndrome signs and symptoms

        Exclusion Criteria:

          -  The lack to meet inclusion criterions, the presence of cognitive impairment,
             kinesiophobia tumors, cancer, recent (affected) upper limb surgery or trauma,
             pregnancy, , deformities of the (affected) upper limb, recent skin injuries or
             infections (in the affected upper limb), autoimmune inflammatory conditions or flu
             type symptoms, allergy to gabapentin, and also: participants must not be (during the
             present investigation) under any type of pain reducing treatment (conservative,
             homeopathic, invasive or not invasive).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Perez, MD</last_name>
    <role>Study Chair</role>
    <affiliation>INSALUD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francisco H Unda, PhD</last_name>
    <phone>0034982410289</phone>
    <email>5299559@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ciudad Hospitalaria Enrique Tejera</name>
      <address>
        <city>Valencia</city>
        <state>Carabobo</state>
        <zip>2001</zip>
        <country>Venezuela</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Venezuela</country>
  </location_countries>
  <reference>
    <citation>Nagle RJ, Thwaite BC. Modeling effects on impulsivity with learning disabled children. J Learn Disabil. 1979 May;12(5):331-6.</citation>
    <PMID>521680</PMID>
  </reference>
  <reference>
    <citation>Davis PT, Hulbert JR, Kassak KM, Meyer JJ. Comparative efficacy of conservative medical and chiropractic treatments for carpal tunnel syndrome: a randomized clinical trail. J Manipulative Physiol Ther. 1998 Jun;21(5):317-26.</citation>
    <PMID>9627862</PMID>
  </reference>
  <reference>
    <citation>Banta CA. A prospective, nonrandomized study of iontophoresis, wrist splinting, and antiinflammatory medication in the treatment of early-mild carpal tunnel syndrome. J Occup Med. 1994 Feb;36(2):166-8.</citation>
    <PMID>8176515</PMID>
  </reference>
  <reference>
    <citation>Hesami O, Haghighatzadeh M, Lima BS, Emadi N, Salehi S. The effectiveness of gabapentin and exercises in the treatment of carpal tunnel syndrome: a randomized clinical trial. J Exerc Rehabil. 2018 Dec 27;14(6):1067-1073. doi: 10.12965/jer.1836420.210. eCollection 2018 Dec.</citation>
    <PMID>30656171</PMID>
  </reference>
  <reference>
    <citation>Dosenovic S, Jelicic Kadic A, Miljanovic M, Biocic M, Boric K, Cavar M, Markovina N, Vucic K, Puljak L. Interventions for Neuropathic Pain: An Overview of Systematic Reviews. Anesth Analg. 2017 Aug;125(2):643-652. doi: 10.1213/ANE.0000000000001998. Review.</citation>
    <PMID>28731977</PMID>
  </reference>
  <reference>
    <citation>Sanz DR, Solano FU, López DL, Corbalan IS, Morales CR, Lobo CC. Effectiveness of median nerve neural mobilization versus oral ibuprofen treatment in subjects who suffer from cervicobrachial pain: a randomized clinical trial. Arch Med Sci. 2018 Jun;14(4):871-879. doi: 10.5114/aoms.2017.70328. Epub 2017 Sep 26.</citation>
    <PMID>30002707</PMID>
  </reference>
  <reference>
    <citation>Calvo-Lobo C, Unda-Solano F, López-López D, Sanz-Corbalán I, Romero-Morales C, Palomo-López P, Seco-Calvo J, Rodríguez-Sanz D. Is pharmacologic treatment better than neural mobilization for cervicobrachial pain? A randomized clinical trial. Int J Med Sci. 2018 Mar 8;15(5):456-465. doi: 10.7150/ijms.23525. eCollection 2018.</citation>
    <PMID>29559834</PMID>
  </reference>
  <reference>
    <citation>Rodríguez-Sanz D, López-López D, Unda-Solano F, Romero-Morales C, Sanz-Corbalán I, Beltran-Alacreu H, Calvo-Lobo C. Effects of Median Nerve Neural Mobilization in Treating Cervicobrachial Pain: A Randomized Waiting List-Controlled Clinical Trial. Pain Pract. 2018 Apr;18(4):431-442. doi: 10.1111/papr.12614. Epub 2017 Nov 20.</citation>
    <PMID>28734105</PMID>
  </reference>
  <reference>
    <citation>Basson A, Olivier B, Ellis R, Coppieters M, Stewart A, Mudzi W. The Effectiveness of Neural Mobilization for Neuromusculoskeletal Conditions: A Systematic Review and Meta-analysis. J Orthop Sports Phys Ther. 2017 Sep;47(9):593-615. doi: 10.2519/jospt.2017.7117. Epub 2017 Jul 13. Review.</citation>
    <PMID>28704626</PMID>
  </reference>
  <reference>
    <citation>Ballestero-Pérez R, Plaza-Manzano G, Urraca-Gesto A, Romo-Romo F, Atín-Arratibel MLÁ, Pecos-Martín D, Gallego-Izquierdo T, Romero-Franco N. Effectiveness of Nerve Gliding Exercises on Carpal Tunnel Syndrome: A Systematic Review. J Manipulative Physiol Ther. 2017 Jan;40(1):50-59. doi: 10.1016/j.jmpt.2016.10.004. Epub 2016 Nov 11. Review.</citation>
    <PMID>27842937</PMID>
  </reference>
  <reference>
    <citation>Eren Y, Yavasoglu NG, Comoglu SS. The relationship between QDASH scale and clinical, electrophysiological findings in carpal tunnel syndrome. Adv Clin Exp Med. 2018 Jan;27(1):71-75. doi: 10.17219/acem/67947.</citation>
    <PMID>29521045</PMID>
  </reference>
  <reference>
    <citation>Ginanneschi F, Cioncoloni D, Bigliazzi J, Bonifazi M, Lorè C, Rossi A. Sensory axons excitability changes in carpal tunnel syndrome after neural mobilization. Neurol Sci. 2015 Sep;36(9):1611-5. doi: 10.1007/s10072-015-2218-x. Epub 2015 Apr 21.</citation>
    <PMID>25896622</PMID>
  </reference>
  <reference>
    <citation>Yücel H, Seyithanoğlu H. Choosing the most efficacious scoring method for carpal tunnel syndrome. Acta Orthop Traumatol Turc. 2015;49(1):23-9. doi: 10.3944/AOTT.2015.13.0162.</citation>
    <PMID>25803249</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 28, 2020</study_first_submitted>
  <study_first_submitted_qc>March 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2020</study_first_posted>
  <last_update_submitted>March 28, 2020</last_update_submitted>
  <last_update_submitted_qc>March 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Europea de Madrid</investigator_affiliation>
    <investigator_full_name>Francisco Unda Solano</investigator_full_name>
    <investigator_title>Biomedicine Doctorate Program Investigator</investigator_title>
  </responsible_party>
  <keyword>Pain management</keyword>
  <keyword>Physiotherapy</keyword>
  <keyword>Manual therapy</keyword>
  <keyword>Median nerve neural mobilization</keyword>
  <keyword>Neural mobilization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

